Metrics
2 Record Views
- Title
- WCN24-1132 ACTION3 – Phase 3 study of DMX-200 for the treatment of focal segmental glomerulosclerosis (FSGS)
- Creators
- Jonathon Barratt - University of LeicesterAnant Desai - Nephrology, Amicis Research Centre, CaliforniaAlessia Fornoni - University of MiamiLesley Inker - Tufts UniversityIrene de Lourdes Noronha - MedicinaAlejandra Quevedo - Nephrology, Centro Medico Dra Maffei Investigación Clínica Aplicad, Buenos AiresRobert Shepherd - BD, Dimerix Bioscience Pty Ltd, FitzroyAlisha Smith - Clinical, Dimerix Bioscience Pty Ltd, FitzroyHernan Trimarchi - Nephrology Dept, Hospital Britáinico de Buenos Aires, Buenos AiresLucila Valente - Nephrology Dept, Hospital das Clinicas da UFPE, RECIFEMona Wahba - Nephrology Dept, St Heliers Hospital, LondonMuh Geot Wong - Concord Repatriation General HospitalHiddo Lambers Heerspink - University Medical Center Groningen
- Publication Details
- Kidney international reports, Vol.9(4), pp.S550-S551
- Publisher
- Elsevier Inc
- Academic Unit
- Peggy and Harold Katz Family Drug Discovery Center; Miller School of Medicine
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991032017303902976